23. EFFICACY, SAFETY AND ECONOMIC EVALUATION OF SUBCUTANEOUS RITUXIMAB VERSUS INTRAVENOUS RITUXIMAB IN PATIENTS WITH NON-HODGKIN LYMPHOMA: A SYSTEMATIC REVIEW. Vietnam Journal of Community Medicine, v. 65, n. CĐ 12 - Bệnh viện Thủ Đức, 12 Dec.2024.